The Price of Progress: Understanding Innovation and Affordability of Prescription Drugs

Economic incentives and patent protections drive development of innovative medications. Drug prices are determined by consumer demand, not production costs. Therefore, governmental regulation risks future investment in research and development.

Publication Details

Journal
The American Journal of Managed Care
Published
2024-10-01
DOI
https://doi.org/10.37765/ajmc.2024.89615
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Price of Progress: Understanding Innovation and Affordability of Prescription Drugs

The American Journal of Managed Care
Pharmaceutical Economics and Policy
article

The Price of Progress: Understanding Innovation and Affordability of Prescription Drugs

article en

Abstract

Economic incentives and patent protections drive development of innovative medications. Drug prices are determined by consumer demand, not production costs. Therefore, governmental regulation risks future investment in research and development.

The American Journal of Managed CareVol. 30(10)
Industry, innovation and infrastructure
Openalex Percentile: Top 77%
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Price of Progress: Understanding Innovation and Affordability of Prescription Drugs · The American Journal of Managed Care (2024) | TGRS Research Map | TGRS